CA1271199C - - Google Patents

Info

Publication number
CA1271199C
CA1271199C CA 436838 CA436838A CA1271199C CA 1271199 C CA1271199 C CA 1271199C CA 436838 CA436838 CA 436838 CA 436838 A CA436838 A CA 436838A CA 1271199 C CA1271199 C CA 1271199C
Authority
CA
Canada
Prior art keywords
bromine
chlorine
bases
compounds
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 436838
Other languages
English (en)
Other versions
CA1257595A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CA000599049A priority Critical patent/CA1271199A/en
Application granted granted Critical
Publication of CA1257595A publication Critical patent/CA1257595A/en
Publication of CA1271199C publication Critical patent/CA1271199C/xx
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04Saturated ethers
    • C07C43/13Saturated ethers containing hydroxy or O-metal groups
    • C07C43/135Saturated ethers containing hydroxy or O-metal groups having more than one ether bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08Saturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyridine Compounds (AREA)
CA000436838A 1982-09-17 1983-09-16 5-HALOGEROVINYL-2'-DESOXYURIDINE DERIVATIVES Expired CA1257595A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000599049A CA1271199A (en) 1982-09-17 1989-05-08 Protected cyclopentanols

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8226515 1982-09-17

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000599049A Division CA1271199A (en) 1982-09-17 1989-05-08 Protected cyclopentanols

Publications (2)

Publication Number Publication Date
CA1257595A CA1257595A (en) 1989-07-18
CA1271199C true CA1271199C (da) 1990-07-03

Family

ID=10532974

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000436838A Expired CA1257595A (en) 1982-09-17 1983-09-16 5-HALOGEROVINYL-2'-DESOXYURIDINE DERIVATIVES

Country Status (17)

Country Link
US (1) US4564618A (da)
EP (1) EP0104066B1 (da)
JP (1) JPS5980620A (da)
AT (1) ATE36325T1 (da)
AU (2) AU575022B2 (da)
CA (1) CA1257595A (da)
CZ (1) CZ402691A3 (da)
DE (1) DE3377647D1 (da)
DK (1) DK160271C (da)
ES (2) ES8502978A1 (da)
GB (1) GB2129425B (da)
HK (1) HK84190A (da)
IE (1) IE55921B1 (da)
MX (1) MX9203234A (da)
NZ (1) NZ205619A (da)
SG (1) SG68890G (da)
ZA (1) ZA836902B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719214A (en) * 1985-07-25 1988-01-12 Southern Research Institute Carbocyclic analogues of thymine nucleosides
PT83201A (en) * 1985-08-16 1986-09-01 Glaxo Group Ltd Guanine derivatives
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
EP0516186A3 (en) * 1987-04-16 1993-01-13 Medivir Aktiebolag Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
GB8920457D0 (en) * 1989-09-11 1989-10-25 Glaxo Group Ltd Chemical compounds
USH1142H (en) 1990-11-05 1993-02-02 Optically active cyclobutyl pyrimidine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606943B2 (ja) * 1975-04-01 1985-02-21 三井製薬工業株式会社 1−(α−アルコキシアルキル)−ウラシル類の製造法
US4232154A (en) * 1977-12-13 1980-11-04 United States Of America Carbocyclic analogs of cytosine nucleosides exhibiting antiviral and antineoplasticactivity
US4177348A (en) * 1977-12-13 1979-12-04 United States Government Carbocyclic analogs of cytosine nucleosides
GB1601020A (en) * 1978-04-24 1981-10-21 Stichting Grega Vzw 2'-deoxy-5 (2-halogenovinyl)-uridines
GB2060604B (en) * 1979-10-03 1983-11-23 Univ Birmingham And Stichting E15-(2-halogenovinyl)-2'-deoxycytidines
JPS5738774A (en) * 1980-08-19 1982-03-03 Chugai Pharmaceut Co Ltd Uracil derivative and its preparation
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
NZ199764A (en) * 1981-03-20 1984-08-24 Beecham Group Plc 5-(2-halogenovinyl)-2'-deoxyuridine derivatives and pharmaceutical compositions
EP0072137A1 (en) * 1981-08-01 1983-02-16 Beecham Group Plc Antiviral deoxyuridine compounds
US4396623A (en) * 1981-08-26 1983-08-02 Southern Research Institute Carbocyclic analogs of uracil nucleosides as antiviral agents
HU183567B (en) * 1981-09-07 1984-05-28 Mta Koezponti Kemiai Kutato In Process for preparing /e/-5-/2-bromo-vinyl/-uridine and derivatives thereof
JPS5843993A (ja) * 1981-09-09 1983-03-14 Yamasa Shoyu Co Ltd 1−β−D−アラビノフラノシル−(E)−5−(2−ハロゲノビニル)ウラシル−5′−りん酸およびその製造法
EP0080305A1 (en) * 1981-11-19 1983-06-01 Beecham Group Plc Antiviral 2'-deoxyuridines, their preparation and use
EP0082668A1 (en) * 1981-12-18 1983-06-29 Beecham Group Plc 5-(2-Halogenovinyl)-2'-deoxyuridine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in treating viral infections
DE3620646A1 (de) * 1986-06-20 1987-12-23 Bayer Ag Verfahren zur herstellung von (1r, 4s)-4-hydroxy-2-cyclopentenylestern

Also Published As

Publication number Publication date
DK160271C (da) 1991-07-22
ES532056A0 (es) 1985-08-01
AU1918583A (en) 1984-03-22
GB2129425B (en) 1987-02-11
NZ205619A (en) 1987-09-30
EP0104066A3 (en) 1984-06-06
DK422183A (da) 1984-03-18
EP0104066A2 (en) 1984-03-28
EP0104066B1 (en) 1988-08-10
IE55921B1 (en) 1991-02-27
US4564618A (en) 1986-01-14
AU601583B2 (en) 1990-09-13
JPS5980620A (ja) 1984-05-10
IE832175L (en) 1984-03-17
DE3377647D1 (de) 1988-09-15
DK160271B (da) 1991-02-18
HK84190A (en) 1990-10-25
DK422183D0 (da) 1983-09-16
CZ402691A3 (en) 1993-07-14
SG68890G (en) 1990-10-26
GB8324813D0 (en) 1983-10-19
ES525670A0 (es) 1985-02-01
GB2129425A (en) 1984-05-16
ES8506751A1 (es) 1985-08-01
AU1646588A (en) 1988-08-11
MX9203234A (es) 1992-07-01
ES8502978A1 (es) 1985-02-01
ATE36325T1 (de) 1988-08-15
CA1257595A (en) 1989-07-18
ZA836902B (en) 1985-05-29
AU575022B2 (en) 1988-07-21

Similar Documents

Publication Publication Date Title
ES8700851A1 (es) Procedimiento para la obtencion de acido alquil-1- ciclopropil-1, 4-dihidro-4-oxo-3-quinolincarboxilico.
ATE81858T1 (de) 6-thioxanthinderivate.
ES8802148A1 (es) Procedimiento para preparar derivados de acido quinoloncarboxilico
ES469265A1 (es) Procedimiento para la fabricacion de derivados del acido omega-aminoacilamisulfonico
ES8403437A1 (es) Un procedimiento para obtener derivados de indanilbenzamida.
CA1271199C (da)
EP0144991A3 (en) Polymethosybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
ES484524A1 (es) Procedimiento para la obtencion de derivados de 1-azolil-1- fluorfenoxibutano de efecto fungicida
CA1271748C (en) BENZAZEPINE DERIVATIVES
ES477878A1 (es) Un procedimiento para preparar mercaptoacilaminoacidos sustituidos con halogeno.
ES8304548A1 (es) "procedimiento de preparacion de derivados de fenetanolamina".
ES8801805A1 (es) Procedimiento para la obtencion de nuevos derivados de isoxazol
ES8504829A1 (es) Un procedimiento para la preparacion de un acido -hidroxietilfosfinico
ES473465A1 (es) Procedimiento para la preparacion de triazolo-tieno-diazepin-1-onas
IE44764L (en) Ferrocene derivatives.
GB1491434A (en) 3-aminomethyl-4-homoisotwistane and acid addition salts thereof
ES8308335A1 (es) Un procedimiento para la preparacion de nuevos derivados de desoxiuridina.
JPS5414961A (en) Novel 3-hydroxyazetidine-3-carboxylic derivative
SU1394659A1 (ru) Стабилизатор хлорсодержащих углеводородов
ES8401487A1 (es) Procedimiento de preparacion de derivados oxigenados de diaza-3,7a-ciclohepta -j,k-fluorenos.

Legal Events

Date Code Title Description
MKEX Expiry